According to a recent Australian study known as BANDIT (Baricitinib in New-onset Type 1 Diabetes), a widely used drug has shown promise in slowing the progression of type 1 diabetes.

Autoimmune diseases and cancer are both complex conditions that impact one's health. While cancer and autoimmune diseases are distinct entities, research shows a growing body of evidence suggesting a link between the two.

In a study done at the University of California, Los Angeles (UCLA), researchers examined the impact of mRNA stability on autoimmune disease risk. 

There is a long-held belief that suppressed emotions can contribute to physical illnesses. Experts like Dr. Jolene Brighten believe that there is a connection between suppressed emotions and autoimmune disease.

Antibiotics are a type of medication prescribed to fight bacterial infections, such as strep throat, urinary tract infections, and E. coli. This medication is commonly prescribed to young children and is often overused. Previous studies that explored the links between early antibiotic exposure and the development of autoimmune diseases have shown conflicting results. 

As we age, our immune system becomes less capable of protecting our bodies from infections and diseases. However, researchers at the Mayo Clinic have found that some older individuals have a young immune system, also called "immune youth."

It is well known that autoimmune diseases are more likely to affect women than men. However, researchers still don't completely understand why women are more at risk of developing autoimmune diseases.

There are times when cancer research overlaps with autoimmune research; for example, CAR T-cell therapy—a form of treatment used to fight cancer—has recently been used to treat patients with autoimmune diseases. Along those lines, the Mayo Clinic has achieved a scientific breakthrough in its research on cancer cells, which may lead to advancements in treating type 1 diabetes.

The National Institute of Health (NIH) has created a strategic plan to accelerate the progress in autoimmune disease research by supporting research on preclinical autoimmunity, early diagnosis, and innovative therapies.

Researchers at Johns Hopkins Medicine have discovered a new role for the protein QRICH1 in regulating the immune system, specifically its influence on T cells.

Recently, a new oral medication has been released for treatment, called Leqselvi (deuruxolitinib). It's a JAK inhibitor made for those with severe alopecia, where the drug targets immune pathways involved in inflammation.

In South Korea, researchers developed a high-resolution genetic analysis tool in order to decode complex immune-related gene clusters that are linked to diseases like lupus.

A study published by BMJ Mental Health finds that people with autoimmune diseases are twice as likely to suffer from mood disorders such as depression, anxiety, or bipolar disorder.

Recently, various parts of the world have experienced an increase in extreme weather events, including heat waves, wildfires, and storms, which have caused power outages, air pollution, and floods.

A research team from Japan discovered that increased levels of certain immune cells may be responsible for the different levels of presentation of an autoimmune disease called systemic sclerosis (or scleroderma).

To receive an accurate diagnosis for celiac disease, many patients have to eat gluten regularly before undergoing lab tests.

Researchers at the University of Cambridge are conducting groundbreaking research to better understand patient experiences of flares in autoimmune diseases.

Living with an autoimmune disease can be isolating. It’s often hard to find others who truly understand the challenges of navigating symptoms, treatments, and the emotional toll that comes with them.